{"id":38045,"date":"2025-07-28T16:02:08","date_gmt":"2025-07-28T08:02:08","guid":{"rendered":"https:\/\/flcube.com\/?p=38045"},"modified":"2025-07-28T16:02:09","modified_gmt":"2025-07-28T08:02:09","slug":"tibet-aim-pharms-major-shareholder-transfers-stake-to-beijing-fuhao","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=38045","title":{"rendered":"Tibet Aim Pharm&#8217;s Major Shareholder Transfers Stake to Beijing Fuhao"},"content":{"rendered":"\n<p>China-based Tibet Aim Pharm, Inc. (<a href=\"https:\/\/www.google.com\/finance\/quote\/002826:SHE\">SHE: 002826<\/a>) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (&#8220;Beijing Fuhao&#8221;).<\/p>\n\n\n\n<p><strong>Agreement Details<\/strong><br>Under the agreement, Beijing Fuhao will acquire 43,855,883 shares of Tibet Aim Pharm from Gao Fan, representing 23.00% of the company&#8217;s total shares. Upon completion of this equity change, Beijing Fuhao will become the controlling shareholder of Tibet Aim Pharm, holding 23.00% of the shares. Consequently, the actual controller of Tibet Aim Pharm will change from Gao Fan to Yao Jinbo.<\/p>\n\n\n\n<p><strong>Supplementary Agreement<\/strong><br>The supplementary agreement outlines commitments from both parties to collaborate and ensure that multiple subsidiaries of Tibet Aim Pharm fulfill agreed matters. This includes the performance commitment and the recovery of funds.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":38047,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[20,4248,4247],"class_list":["post-38045","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-finance","tag-she-002826","tag-tibet-aim-pharm"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Tibet Aim Pharm&#039;s Major Shareholder Transfers Stake to Beijing Fuhao - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (&quot;Beijing Fuhao&quot;).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=38045\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tibet Aim Pharm&#039;s Major Shareholder Transfers Stake to Beijing Fuhao\" \/>\n<meta property=\"og:description\" content=\"China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (&quot;Beijing Fuhao&quot;).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=38045\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-28T08:02:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-28T08:02:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2815.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Tibet Aim Pharm&#8217;s Major Shareholder Transfers Stake to Beijing Fuhao\",\"datePublished\":\"2025-07-28T08:02:08+00:00\",\"dateModified\":\"2025-07-28T08:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045\"},\"wordCount\":146,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2815.webp\",\"keywords\":[\"Finance\",\"SHE: 002826\",\"Tibet Aim Pharm\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38045#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=38045\",\"name\":\"Tibet Aim Pharm's Major Shareholder Transfers Stake to Beijing Fuhao - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2815.webp\",\"datePublished\":\"2025-07-28T08:02:08+00:00\",\"dateModified\":\"2025-07-28T08:02:09+00:00\",\"description\":\"China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (\\\"Beijing Fuhao\\\").\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38045\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2815.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2815.webp\",\"width\":1080,\"height\":608,\"caption\":\"Tibet Aim Pharm's Major Shareholder Transfers Stake to Beijing Fuhao\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38045#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tibet Aim Pharm&#8217;s Major Shareholder Transfers Stake to Beijing Fuhao\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tibet Aim Pharm's Major Shareholder Transfers Stake to Beijing Fuhao - Insight, China&#039;s Pharmaceutical Industry","description":"China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (\"Beijing Fuhao\").","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=38045","og_locale":"en_US","og_type":"article","og_title":"Tibet Aim Pharm's Major Shareholder Transfers Stake to Beijing Fuhao","og_description":"China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (\"Beijing Fuhao\").","og_url":"https:\/\/flcube.com\/?p=38045","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-28T08:02:08+00:00","article_modified_time":"2025-07-28T08:02:09+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2815.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=38045#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=38045"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Tibet Aim Pharm&#8217;s Major Shareholder Transfers Stake to Beijing Fuhao","datePublished":"2025-07-28T08:02:08+00:00","dateModified":"2025-07-28T08:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=38045"},"wordCount":146,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=38045#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2815.webp","keywords":["Finance","SHE: 002826","Tibet Aim Pharm"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=38045#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=38045","url":"https:\/\/flcube.com\/?p=38045","name":"Tibet Aim Pharm's Major Shareholder Transfers Stake to Beijing Fuhao - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=38045#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=38045#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2815.webp","datePublished":"2025-07-28T08:02:08+00:00","dateModified":"2025-07-28T08:02:09+00:00","description":"China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller, Gao Fan, has entered into a share transfer agreement and supplementary agreement with Beijing Fuhao Enterprise Management Partnership (Limited Partnership) (\"Beijing Fuhao\").","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=38045#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=38045"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=38045#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2815.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2815.webp","width":1080,"height":608,"caption":"Tibet Aim Pharm's Major Shareholder Transfers Stake to Beijing Fuhao"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=38045#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Tibet Aim Pharm&#8217;s Major Shareholder Transfers Stake to Beijing Fuhao"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2815.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38045"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38045\/revisions"}],"predecessor-version":[{"id":38048,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38045\/revisions\/38048"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/38047"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}